These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6133641)

  • 21. What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience.
    Furberg CD; Byington RP
    Circulation; 1983 Jun; 67(6 Pt 2):I98-101. PubMed ID: 6133654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing beta-blocker use after myocardial infarction.
    Howard PA; Ellerbeck EF
    Am Fam Physician; 2000 Oct; 62(8):1853-60, 1865-6. PubMed ID: 11057841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
    Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-blockers after myocardial infarction.
    Med Lett Drugs Ther; 1979 Dec; 21(25):101. PubMed ID: 44732
    [No Abstract]   [Full Text] [Related]  

  • 27. beta-Adrenergic blocking agents in the post-myocardial infarction patient.
    Goldstein S
    Arch Intern Med; 1979 Oct; 139(10):1089-90. PubMed ID: 39535
    [No Abstract]   [Full Text] [Related]  

  • 28. From the NIH: Implications of the recent beta-blocker clinical trials for patients after myocardial infarction.
    JAMA; 1983 May; 249(18):2482-3. PubMed ID: 6133013
    [No Abstract]   [Full Text] [Related]  

  • 29. Modern drug treatment--No. 8. Drugs and the prevention of death from myocardial infarction.
    Graham IM
    Ir Med J; 1982 Aug; 75(8):291-6. PubMed ID: 6127329
    [No Abstract]   [Full Text] [Related]  

  • 30. [Coronary disease and antihypertensive treatment with beta blockers in older patients].
    Wikstrand J
    Cardiologia; 1984; 29(1-2):129-44. PubMed ID: 6152540
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical experiences with acute beta blockade in acute myocardial infarction].
    Pedersen F; Bechsgaard P; Nielsen PB; Rasmussen SL
    Ugeskr Laeger; 1979 Nov; 141(45):3086-9. PubMed ID: 43002
    [No Abstract]   [Full Text] [Related]  

  • 33. [Beta-blockers and secondary prevention after myocardial infarction].
    Kher A; Jaillon P
    Therapie; 1984; 39(2):189-96. PubMed ID: 6145232
    [No Abstract]   [Full Text] [Related]  

  • 34. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Beta-blocker in secondary prevention of cardiovascular disease].
    Sauer G
    Z Kardiol; 2003 Jan; 92(1):24-30. PubMed ID: 12545298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost.
    Zuckerman IH; Weiss SR; McNally D; Layne B; Mullins CD; Wang J
    Am J Manag Care; 2004 Jul; 10(7 Pt 2):493-500. PubMed ID: 15298236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of pharmacotherapy in secondary prevention of myocardial infarction and death.
    Gorlin R; Fuster V
    Mt Sinai J Med; 1984 Jun; 51(3):229-36. PubMed ID: 6146929
    [No Abstract]   [Full Text] [Related]  

  • 38. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.
    Kramer JM; Hammill B; Anstrom KJ; Fetterolf D; Snyder R; Charde JP; Hoffman BS; Allen LaPointe N; Peterson E
    Am Heart J; 2006 Sep; 152(3):454.e1-8. PubMed ID: 16923412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction.
    Smith DH; Kramer JM; Perrin N; Platt R; Roblin DW; Lane K; Goodman M; Nelson WW; Yang X; Soumerai SB
    Arch Intern Med; 2008 Mar; 168(5):477-83; discussion 483; quiz 447. PubMed ID: 18332291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reduction of mortality in acute myocardial infarction in patients treated with alprenolol. Preliminary results].
    Andersen M; Bechsgaard P; Frederiksen J; Hansen DA; Jürgensen HJ; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL
    Ugeskr Laeger; 1979 Nov; 141(45):3083-6. PubMed ID: 43001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.